Tuis0P8 • FRA
add
Penumbra Inc
Vorige sluiting
€291,00
Dagwisseling
€290,60 - €292,30
Jaarwisseling
€193,10 - €306,40
Markkapitalisasie
13,37 mjd USD
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 385,38 m | 22,14% |
Bedryfskoste | 202,90 m | 20,81% |
Netto inkomste | 47,34 m | 40,55% |
Netto winsgrens | 12,28 | 14,98% |
Wins per aandeel | 1,18 | 21,65% |
EBITDA | 63,49 m | 39,16% |
Effektiewe belastingkoers | 25,60% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 544,82 m | 60,18% |
Totale bates | 1,83 mjd | 19,13% |
Totale aanspreeklikheid | 398,92 m | 4,36% |
Totale ekwiteit | 1,43 mjd | — |
Uitstaande aandele | 39,24 m | — |
Prys om te bespreek | 8,00 | — |
Opbrengs op bates | 8,29% | — |
Opbrengs op kapitaal | 9,19% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 47,34 m | 40,55% |
Kontant van bedrywe | 86,48 m | 69,22% |
Kontant van beleggings | -225,65 m | -1 959,76% |
Kontant van finansiering | 5,06 m | -16,66% |
Netto kontantverandering | -134,13 m | -405,35% |
Beskikbare kontantvloei | 50,26 m | 55,13% |
Meer oor
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend. Wikipedia
Gestig
2004
Webwerf
Werknemers
4 700
